Effect of probiotics on kidney tissue in an experimental diabetes model
Abstract
Purpose: Diabetes, a major public health issue, is an endocrine and metabolic disease that causes damage to various tissues, including the kidneys. Probiotics are thought to play a beneficial role in the prevention and treatment of diseases when used in sufficient amounts. This study aims to investigate the effects of probiotic supplementation on kidney tissue damage induced by diabetes.
Materials and methods: A total of 34 rats were divided into five groups. The control group (K, n=5) received PBS, while the probiotic-only group (Pm, n=5) was given probiotics (0.6 mg/kg). In the diabetes group (Dm, n=8), diabetes was induced using streptozotocin (50 mg/kg). The PmD group (n=8) received probiotic supplementation before diabetes induction, and probiotic administration continued after diabetes was induced. In contrast, the DmP group (n=8) first underwent diabetes induction, followed by probiotic supplementation. Kidney tissues were examined histopathologically and immunohistochemically, with Bcl-2 and alpha-SMA antibody expressions evaluated.
Results: No histopathological alterations were observed in the control group. In the Dm group, moderate-to-mild nephrotoxicity was detected, while the probiotic-supplemented diabetes groups exhibited mild nephrotoxicity. Bcl-2 expression was decreased in the Dm group but was found to be higher in the DmP and PmD groups. Conversely, alpha-SMA expression was elevated in the Dm group, whereas it was lower in the DmP and PmD groups.
Conclusion: Histopathological and immunohistochemical analyses indicate that probiotics exert a protective effect against diabetes-induced kidney damage.
Keywords
Diabetes, probiotic, kidney, alpha-SMA, Bcl-2
Supporting Institution
This study was supported by Pamukkale University Scientific Research Projects Coordination Office (BAP Project no: 2021SABE018)
Project Number
2021SABE018
Ethical Statement
Permission for the study was obtained from Pamukkale University Animal Experiments Ethics Committee with the decision numbered and dated PAUHDEK-2021/37.
Thanks
We would like to thank Pamukkale University Experimental Animal Research Unit (DEHAB) for their contribution during the experiment.
References
- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36 Suppl 1(Suppl 1):S67-S74. doi:10.2337/dc13-S067
- World Health Organization Available at: https://www.who.int/data/gho/publications/world-health-statistics. Accessed 25.06.2024
- Me TA. Hastalıklarda beslenme tedavisi. İstanbul: Hatipoğlu Matbaacılık; 2013;1:277-304.
- Kanchan G, Dagle P, Pushpalata C, Joshi Y, Kadam V. A review on some nephroprotective medicinal plants. International Journal of Pharmaceutical Sciences and Research. 2012;2012(8):2451. doi:10.13040/ijpsr.0975-8232.3(8).2451-54
- Lu L, Zhong Z, Gu J, Nan K, Zhu M, Miao C. ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy. Mol Med. 2021;27(1):74. Published 2021 Jul 8. doi:10.1186/s10020-021-00339-7
- American Diabetes Association. Diabetes and employment. Diabetes Care. 2009;32 Suppl 1(Suppl 1):S80-S84. doi:10.2337/dc09-S080
- Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1989;32(3):151-159. doi:10.1007/BF00265086
- Azpiroz F, Malagelada C. Diabetic neuropathy in the gut: pathogenesis and diagnosis. Diabetologia. 2016;59(3):404-408. doi:10.1007/s00125-015-3831-1
- Wu SL. Staging of type 2 diabetes mellitus. Genet Mol Res. 2015;14(1):2118-2121. Published 2015 Mar 20. doi:10.4238/2015.March.20.22
- Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55-60. doi:10.1038/nature11450
